FOXO3a: A novel player in thyroid carcinogenesis?

Endocrine-Related Cancer

Volumn 16, Issue 1, 2009, Pages 189-199

  Karger, Stefan ^a   Weidinger, Carl ^a   Krause, Kerstin ^a   Sheu, Sien Yi ^b   Aigner, Thomas ^a   Gimm, Oliver ^c   Schmid, Kurt Werner ^b   Dralle, Henning ^c   Fuhrer, Dagmar ^a  

^a UNIVERSITY OF LEIPZIG   (Germany)

^b UNIVERSITY OF DUISBURG ESSEN   (Germany)

^c MARTIN LUTHER UNIVERSITY HALLE WITTENBERG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

BIM PROTEIN; CYCLIN DEPENDENT KINASE INHIBITOR 1B; GROWTH ARREST AND DNA DAMAGE INDUCIBLE PROTEIN 45; PROTEIN KINASE B; STRESS ACTIVATED PROTEIN KINASE; TRANSCRIPTION FACTOR FKHRL1; ANTIDIABETIC AGENT; APOPTOSIS REGULATORY PROTEIN; BCL 2 LIKE PROTEIN 11; BCL-2-LIKE PROTEIN 11; CYCLIC AMP DEPENDENT PROTEIN KINASE; FORKHEAD TRANSCRIPTION FACTOR; FOXO3A PROTEIN, RAT; INSULIN; MEMBRANE PROTEIN; ONCOPROTEIN; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN KINASE C; SIGNAL PEPTIDE; THYROTROPIN;

ANIMAL CELL; ARTICLE; CARCINOGENESIS; CONTROLLED STUDY; GENE EXPRESSION; GENE TARGETING; HUMAN; HUMAN TISSUE; IN VITRO STUDY; IN VIVO STUDY; NONHUMAN; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN PHOSPHORYLATION; RAT; THYROID CANCER; THYROID CELL; THYROID FOLLICULAR CARCINOMA; TRANSCRIPTION REGULATION; ADENOCARCINOMA; ANIMAL; APOPTOSIS; CYTOPLASM; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; OXIDATIVE STRESS; PATHOLOGY; PHOSPHORYLATION; PHYSIOLOGY; SIGNAL TRANSDUCTION; THYROID TUMOR; TUMOR CELL LINE;

1-PHOSPHATIDYLINOSITOL 3-KINASE; ADENOCARCINOMA, FOLLICULAR; ANIMALS; APOPTOSIS; APOPTOSIS REGULATORY PROTEINS; CELL LINE, TUMOR; CYCLIC AMP-DEPENDENT PROTEIN KINASES; CYCLIN-DEPENDENT KINASE INHIBITOR P27; CYTOPLASM; FORKHEAD TRANSCRIPTION FACTORS; GENE EXPRESSION REGULATION, NEOPLASTIC; HYPOGLYCEMIC AGENTS; INSULIN; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; JNK MITOGEN-ACTIVATED PROTEIN KINASES; MEMBRANE PROTEINS; OXIDATIVE STRESS; PHOSPHORYLATION; PROTEIN KINASE C; PROTO-ONCOGENE PROTEINS; PROTO-ONCOGENE PROTEINS C-AKT; RATS; SIGNAL TRANSDUCTION; THYROID NEOPLASMS; THYROTROPIN;

EID: 65549116919     PISSN: 13510088     EISSN: 14796821     Source Type: Journal    
DOI: 10.1677/ERC-07-0283     Document Type: Article

References (40)

1. Ambesi-Impiombato FS, Parks LA & Coon HG 1980 Culture of hormone-dependent fuctional ephitelial cells from rat thyroids. PNAS 77 3455-3459.
2. Bartkova J, Horejsi Z, Koed K, Kramer A, Tort F, Zieger K, Guldberg P, Sehested M, Nesland JM, Lukas C et al. 2005 DNA damage response as a candidate anti-cancer barrier in early human tumorigenesis. Nature 434 864-870.
3. Birkenkamp KU & Coffer PJ 2003 Regulation of cell survival and proliferation by the forkhead box, class O (FOXO) subfamily of forkhead transcription factors. Biochemical Society Transactions 31 292-297.
4. Bouillet P, Metcalf D, Huang DC, Tarlinton DM, Kay TW, Kontgen F, Adams JM & Strasser A 1999 Proapoptotic Bcl-2 relative Bim required for certain apoptotic responses, leukocyte homeostasis, and to preclude autoimmunity. Science 286 1735-1738.
5. Brunet A, Sweeney LB, Sturgill JF, Chua KF, Greer PL, Lin Y, Tran H, Ross SE, Mostoslavsky R, Cohen HY et al. 2004 Stress-dependent regulation of FOXO transcription factors by the SIRT1 deacetylase. Science 303 2011-2015.
6. Dahia PL, Marsh DJ, Zheng Z, Zedenius J, Komminoth P, Frisk T, Wallin G, Parsons R, Longy M, Larsson C et al. 1997 Somatic deletions and mutations in the Cowden disease gene, PTEN, in sporadic thyroid tumors. Cancer Research 57 4710-4713.
7. Dijkers PF, Medema RH, Lammers JW, Koenderman L & Coffer PJ 2000a Expression of the pro-apoptotic Bcl-2 family member Bim is regulated by the forkhead transcription factor FKHR-L1. Current Biology 10 1201-1204.
8. Dijkers PF, Medema RH, Pals C, Banerji L, Thomas NS, Lam EW, Burgering BM, Raaijmakers JA, Lammers JW, Koenderman L et al. 2000b Forkhead transcription factor FKHR-L1 modulates cytokine-dependent transcriptional regulation of p27(KIP1). Molecular and Cellular Biology 20 9138-9148.
9. Essers MA, Vries-Smits LM, Barker N, Polderman PE, Burgering BM & Korswagen HC 2005 Functional interaction between beta-catenin and FOXO in oxidative stress signaling. Science 308 1181-1184.
10. Eszlinger M, Krohn K, Berger K, Lauter J, Kropf S, Beck M, Fuhrer D & Paschke R 2005 Gene expression analysis reveals evidence for increased expression of cell cycle-associated genes and Gq-protein-protein kinase C signaling in cold thyroid nodules. Journal of Clinical Endocrinology and Metabolism 90 1163-1170.
11. Fagin JA 2002 Minireview: branded from the start-distinct oncogenic initiating events may determine tumor fate in the thyroid. Molecular Endocrinology 16 903-911.
12. Fuhrer D, Eszlinger M, Karger S, Krause K, Engelhardt C, Hasenclever D, Dralle H & Paschke R 2005 Evaluation of insulin-like growth factor II, cyclooxygenase-2, ets-1 and thyroid-specific thyroglobulin mRNA expression in benign and malignant thyroid tumours. European Journal of Endocrinology 152 785-790.
13. Greer EL, Oskoui PR, Banko MR, Maniar JM, Gygi MP, Gygi SP & Brunet A 2007 The energy sensor AMP-activated protein kinase directly regulates the mammalian FOXO3a transcription factor. Journal of Biological Chemistry 282 30107-30119.
14. Gupta SK, Gupta M, Hoffman B & Liebermann DA 2006 Hematopoietic cells from gadd45a-deficient and gadd45b-deficient mice exhibit impaired stress responses to acute stimulation with cytokines, myeloablation and inflammation. Oncogene 25 5537-5546.
15. van der Heide LP, Hoekman MF & Smidt MP 2004 The ins and outs of FoxO shuttling: mechanisms of FoxO translocation and transcriptional regulation. Biochemical Journal 380 297-309.
16. Hildesheim J, Bulavin DV, Anver MR, Alvord WG, Hollander MC, Vardanian L & Fornace AJ Jr 2002 Gadd45a protects against UV irradiation-induced skin tumors, and promotes apoptosis and stress signaling via MAPK and p53. Cancer Research 62 7305-7315.
17. Hollander MC, Sheikh MS, Bulavin DV, Lundgren K, Augeri-Henmueller L, Shehee R, Molinaro TA, Kim KE, Tolosa E, Ashwell JD et al. 1999 Genomic instability in Gadd45a-deficient mice. Nature Genetics 23 176-184.
18. van der Horst A & Burgering BM 2007 Stressing the role of FoxO proteins in lifespan and disease. Nature Reviews. Molecular Cell Biology 8 440-450.
19. Huang H & Tindall DJ 2006 FOXO factors: a matter of life and death. Future Oncology 2 83-89.
20. Kimura T, Van Keymeulen A, Golstein J, Fusco A, Dumont JE & Roger PP 2001 Regulation of thyroid cell proliferation by tsh and other factors: a critical evaluation of in vitro models. Endocrine Reviews 22 631-656.
21. Krause K, Karger S, Gimm O, Sheu SY, Dralle H, Tannapfel A, Schmid KW, Dupuy C & Fuhrer D 2007a Characterisation of DEHAL1 expression in thyroid pathologies. Experimental Cell Research 156 295-301.
22. Krause K, Karger S, Schierhorn A, Poncin S, Many MC & Fuhrer D 2007b Proteomic profiling of cold thyroid nodules. Endocrinology 148 1754-1763.
23. Kroll TG, Sarraf P, Pecciarini L, Chen CJ, Mueller E, Spiegelman BM & Fletcher JA 2000 PAX8-PPAR-gamma1 fusion oncogene in human thyroid carcinoma (corrected). Science 289 1357-1360.
24. Lee YJ, Lee JH & Han HJ 2006 Extracellular adenosine triphosphate protects oxidative stress-induced increase of p21(WAF1/Cip1) and p27(Kip1) expression in primary cultured renal proximal tubule cells: role of PI3K and Akt signaling. Journal of Cellular Physiology 209 802-810.
25. Maier J, van Steeg H, van Oostrom C, Karger S, Paschke R & Krohn K 2006 Deoxyribonucleic acid damage and spontaneous mutagenesis in the thyroid gland of rats and mice. Endocrinology 147 3391-3397.
26. Medina DL & Santisteban P 2000 Thyrotropin-dependent proliferation of in vitro rat thyroid cell systems. Experimental Cell Research 143 161-178.
27. Ni YG, Wang N, Cao DJ, Sachan N, Morris DJ, Gerard RD, Kuro O, Rothermel BA & Hill JA 2007 FoxO transcription factors activate Akt and attenuate insulin signaling in heart by inhibiting protein phosphatases. PNAS 104 20517-20522.
28. Nicholson KM & Anderson NG 2002 The protein kinase B/Akt signalling pathway in human malignancy. Cellular Signalling 14 381-395.
29. Nikiforova MN, Lynch RA, Biddinger PW, Alexander EK, Dorn GW, Tallini G, Kroll TG & Nikiforov YE 2003 RAS point mutations and PAX8-PPAR gamma rearrangement in thyroid tumors: evidence for distinct molecular pathways in thyroid follicular carcinoma. Journal of Clinical Endocrinology and Metabolism 88 2318-2326.
30. Paes JE & Ringel MD 2008 Dysregulation of the phosphatidylinositol 3-kinase pathway in thyroid neoplasia. Endocrinology and Metabolism Clinics of North America 37 375-387.
31. Roger PP & Dumont JE 1984 Factors controlling proliferation and differentiation of canine thyroid cells cultured in reduced serum conditions: effects of thyrotropin, cyclic AMP and growth factors. Molecular and Cellular Endocrinology 36 79-93.
32. Santoro M, Melillo RM, Carlomagno F, Vecchio G & Fusco A 2004 Minireview: RET: normal and abnormal functions. Endocrinology 145 5448-5451.
33. Shinohara M, Chung YJ, Saji M & Ringel MD 2007 AKT in thyroid tumorigenesis and progression. Endocrinology 148 942-947.
34. Song Y, Driessens N, Costa M, De DX, Detours V, Corvilain B, Maenhaut C, Miot F, Van Sande J, Many MC et al. 2007 Roles of hydrogen peroxide in thyroid physiology and disease. Journal of Clinical Endocrinology and Metabolism 10 3764-3773.
35. Stahl M, Dijkers PF, Kops GJ, Lens SM, Coffer PJ, Burgering BM & Medema RH 2002 The forkhead transcription factor FoxO regulates transcription of p27Kip1 and Bim in response to IL-2. Journal of Immunology 168 5024-5031.
36. Tong T, Fan W, Zhao H, Jin S, Fan F, Blanck P, Alomo I, Rajasekaran B, Liu Y, Holbrook NJ et al. 2001 Involvement of the MAP kinase pathways in induction of GADD45 following UV radiation. Experimental Cell Research 269 64-72.
37. Tront JS, Hoffman B & Liebermann DA 2006 Gadd45a suppresses Ras-driven mammary tumorigenesis by activation of c-Jun NH2-terminal kinase and p38 stress signaling resulting in apoptosis and senescence. Cancer Research 66 8448-8454.
38. Wang XW, Zhan Q, Coursen JD, Khan MA, Kontny HU, Yu L, Hollander MC, O'Connor PM, Fornace AJ Jr & Harris CC 1999 GADD45 induction of a G2/M cell cycle checkpoint. PNAS 96 3706-3711.
39. Yamasawa K, Nio Y, Dong M, Yamaguchi K & Itakura M 2002 Clinicopathological significance of abnormalities in Gadd45 expression and its relationship to p53 in human pancreatic cancer. Clinical Cancer Research 8 2563-2569.
40. Zerbini LF & Libermann TA 2005 GADD45 deregulation in cancer: frequently methylated tumor suppressors and potential therapeutic targets. Clinical Cancer Research 11 6409-6413.